ARX Equity Partners nominated for the Central and Eastern Europe Deal of the Year Award

ARX Equity Partners has been selected as a finalist for the third consecutive year for the Real Deals Central and Eastern Europe Deal of the Year Award for Slovenian portfolio company Diagnosticni Center Bled (“DCB”).

ARX acquired DCB in 2015 to develop its already robust business and best-in-class, specialist medical capabilities as a platform to further consolidate and grow its market leading position in the Slovenian diagnostics sector. This objective was successfully achieved during the period of ARX ownership with four strategic add-on acquisitions completed and the company doubling in size. DCB was exited to a strategic investor in early 2020.

ARX Equity Partners acquires Instrumentation Technologies, a global leader in advanced instrumentation for the particle accelerator and proton therapy markets

ARX Equity Partners (“ARX”), a private equity firm focused on the Central European region, has agreed to complete the acquisition of Instrumentation Technologies (“I-Tech”, Founded in 1998 and headquartered in Solkan, Slovenia, I-Tech is the global market leader in the development and assembly of high-specification instrumentation for data acquisition and signal processing used in scientific particle accelerators. Also core to the I-Tech strategy is utilizing the company’s know-how and R&D capabilities to develop instrumentation for medical proton therapy applications as well as broader industrial markets.

The transaction also includes Red Pitaya (, a handheld electronics lab incorporating instruments such as oscilloscopes and signal generators and which is seeing widespread adoption among signal processing engineers, hobbyists and students.

ARX acquired the company from its founders and financial details of the transaction were not disclosed. Completion of the transaction is subject to customary closing conditions. As part of the transaction, ARX agreed to partner with the company´s existing management team who will lead the future growth and development of the Company.